TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 50.00
+0.30 (0.60%)
Aug 19, 2026, 1:30 PM CST
TSH Biopharm Corporation Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 618.68 | 464.54 | 588.34 | 576.59 | 488.9 | 381.89 |
Short-Term Investments | 442.89 | 467.74 | 309.02 | 195.54 | 326.86 | 351.52 |
Cash & Short-Term Investments | 1,062 | 932.28 | 897.36 | 772.12 | 815.77 | 733.41 |
Cash Growth | 15.85% | 3.89% | 16.22% | -5.35% | 11.23% | 1.07% |
Accounts Receivable | 197.2 | 312.34 | 211.68 | 208.33 | 202.55 | 99.07 |
Other Receivables | 3.58 | 2.35 | 2.39 | 2.18 | 1.83 | 1.06 |
Receivables | 200.79 | 314.69 | 214.07 | 210.51 | 204.38 | 100.13 |
Inventory | 146.11 | 155.74 | 176.08 | 118.4 | 107.39 | 73.22 |
Prepaid Expenses | 35.88 | 18.54 | 16.79 | 9.29 | - | - |
Other Current Assets | 44.15 | 1.77 | 0.41 | 3.44 | 15.37 | 13.22 |
Total Current Assets | 1,488 | 1,423 | 1,305 | 1,114 | 1,143 | 919.97 |
Property, Plant & Equipment | 30.44 | 35.64 | 40.41 | 32.68 | 41.64 | 27.36 |
Long-Term Investments | 181.97 | 183.84 | 192.63 | 188.89 | 179.08 | 212.06 |
Goodwill | 247.9 | 247.9 | 247.9 | - | - | - |
Other Intangible Assets | 41.9 | 41.58 | 39.75 | 53.64 | 64.07 | 3.63 |
Long-Term Deferred Tax Assets | 2.67 | 2.67 | 4.01 | 1.51 | 1.8 | 2.01 |
Other Long-Term Assets | 32.6 | 16.8 | 12.78 | 9.39 | 5.62 | 4.39 |
Total Assets | 2,026 | 1,951 | 1,842 | 1,400 | 1,435 | 1,169 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 55.98 | 48.63 | 71.36 | 51.42 | 57.64 | 12.72 |
Accrued Expenses | 52.33 | 67.87 | 56.69 | 35.21 | 37.4 | 44.77 |
Short-Term Debt | - | - | - | - | 20 | - |
Current Portion of Long-Term Debt | - | - | - | - | 18.85 | - |
Current Portion of Leases | 10.07 | 11.95 | 10.1 | 7.4 | 7.32 | 4.57 |
Current Income Taxes Payable | 29.02 | 26.68 | 32.23 | 2.97 | 8.02 | 7.1 |
Current Unearned Revenue | 2.79 | 3.24 | 1.04 | 1.84 | 5.43 | - |
Other Current Liabilities | 193.44 | 68.73 | 37.48 | 34.79 | 50.85 | 16.64 |
Total Current Liabilities | 343.62 | 227.09 | 208.9 | 133.63 | 205.5 | 85.8 |
Long-Term Debt | - | - | - | - | 9.6 | - |
Long-Term Leases | 5.04 | 6.7 | 10.33 | - | 7.36 | - |
Total Liabilities | 348.66 | 233.79 | 219.23 | 133.63 | 222.46 | 85.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 383.98 | 383.98 | 383.98 | 383.98 | 383.98 | 383.98 |
Additional Paid-In Capital | 459.69 | 459.61 | 459.55 | 459.5 | 459.44 | 459.36 |
Retained Earnings | 565.54 | 581.2 | 480.68 | 204.14 | 228.37 | 224.08 |
Comprehensive Income & Other | 5.78 | 17.82 | 67.58 | 59.98 | 22.58 | 16.21 |
Total Common Equity | 1,415 | 1,443 | 1,392 | 1,108 | 1,094 | 1,084 |
Minority Interest | 262.31 | 275.06 | 231.18 | 158.63 | 118.31 | - |
Shareholders' Equity | 1,677 | 1,718 | 1,623 | 1,266 | 1,213 | 1,084 |
Total Liabilities & Equity | 2,026 | 1,951 | 1,842 | 1,400 | 1,435 | 1,169 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 15.11 | 18.64 | 20.43 | 7.4 | 63.13 | 4.57 |
Net Cash (Debt) | 1,046 | 913.64 | 876.93 | 764.73 | 752.64 | 728.84 |
Net Cash Growth | 16.78% | 4.19% | 14.67% | 1.60% | 3.27% | 1.67% |
Net Cash Per Share | 27.20 | 23.75 | 22.81 | 19.90 | 19.57 | 18.96 |
Filing Date Shares Outstanding | 38.4 | 38.4 | 38.4 | 38.4 | 38.4 | 38.4 |
Total Common Shares Outstanding | 38.4 | 38.4 | 38.4 | 38.4 | 38.4 | 38.4 |
Working Capital | 1,145 | 1,196 | 1,096 | 980.13 | 937.41 | 834.17 |
Book Value Per Share | 36.85 | 37.57 | 36.25 | 28.85 | 28.50 | 28.22 |
Tangible Book Value | 1,125 | 1,153 | 1,104 | 1,054 | 1,030 | 1,080 |
Tangible Book Value Per Share | 29.30 | 30.03 | 28.76 | 27.45 | 26.83 | 28.13 |
Land | - | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 |
Buildings | - | 14.2 | 14.2 | 14.2 | 13.94 | 13.94 |
Machinery | - | 48.21 | 47.68 | 33.13 | 31.41 | 22.48 |